996热re视频精品视频这里,国产又色又爽又高潮免费,精品自拍亚洲一区在线,久久久综合九色合综,国产精品亚洲综合一区在线观看

Basic Info

  • Grade: pharmaceutical grade

    Factory Location: Shanghai

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Secatinib is an oral biologic that is a selective inhibitor of wild-type, mutant, and fusion products. It involves rearrangement of the oncogene receptor tyrosine kinase during transfection (RET) and has potential anti-tumor activity. After oral administration, secatinib can selectively bind to wild-type RET as well as various RET mutants and fusion products containing RET, and use them as targets. This will lead to inhibition of the growth of tumor cells exhibiting increased RET activity. In addition, secatinib can also target, bind, and inhibit vascular endothelial growth factor receptors 1 (VEGFR1) and 3 (VEGFR3), as well as fibroblast growth factor receptors 1 (FGFR1), 2 (FGFR2), and 3 (FGFR3). Overexpression, activation mutations, and fusion of RET lead to upregulation and/or overactivation of RET tyrosine kinase activity in various cancer cell types; The imbalance of RET activity plays a crucial role in the development and progression of these cancers.
Send your message to this supplier
  • From:
  • To:
    Shanghai Hope-chem Co.,Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    -?Supports?jpg,?jpeg,?png,
    ?gif,?pdf,?doc,?docx,
    ?xls,?xlsx,?txt,?rar?and?zip
    -?Max?upload?3?files;
    ?Max??total?size:?3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service